Post a Free Blog

Submit A Press Release

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Action
Animation
ATP Tour (ATP)
Auto Racing
Baseball
Basketball
Boxing
Breaking News
Business
Business
Business Newsletter
Call of Duty (CALLOFDUTY)
Canadian Football League (CFL)
Car
Celebrity
Champions Tour (CHAMP)
Comedy
CONCACAF
Counter Strike Global Offensive (CSGO)
Crime
Dark Comedy
Defense of the Ancients (DOTA)
Documentary and Foreign
Drama
eSports
European Tour (EPGA)
Fashion
FIFA
FIFA Women’s World Cup (WWC)
FIFA World Cup (FIFA)
Fighting
Football
Formula 1 (F1)
Fortnite
Golf
Health
Hockey
Horror
IndyCar Series (INDY)
International Friendly (FRIENDLY)
Kids & Family
League of Legends (LOL)
LPGA
Madden
Major League Baseball (MLB)
Mixed Martial Arts (MMA)
MLS
Movie and Music
Movie Trailers
Music
Mystery
NASCAR Cup Series (NAS)
National Basketball Association (NBA)
National Football League (NFL)
National Hockey League (NHL)
National Women's Soccer (NWSL)
NBA Development League (NBAGL)
NBA2K
NCAA Baseball (NCAABBL)
NCAA Basketball (NCAAB)
NCAA Football (NCAAF)
NCAA Hockey (NCAAH)
Olympic Mens (OLYHKYM)
Other
Other Sports
Overwatch
PGA
Politics
Premier League (PREM)
Romance
Sci-Fi
Science
Soccer
Sports
Sports
Technology
Tennis
Thriller
Truck Series (TRUCK)
True Crime
Ultimate Fighting Championship (UFC)
Uncategorized
US
Valorant
Western
Women’s National Basketball Association (WNBA)
Women’s NCAA Basketball (WNCAAB)
World
World Cup Qualifier (WORLDCUP)
WTA Tour (WTA)
Xfinity (XFT)
XFL
0
-- Advertisement --spot_img
HomeBusinessMorgan Stanley Reiterates Equalweight Rating for Solventum, Highlights Focus on Culture and...

Morgan Stanley Reiterates Equalweight Rating for Solventum, Highlights Focus on Culture and Growth Repositioning

Add to Favorite
Added to Favorite


Morgan Stanley analysts reiterated their Equalweight rating and maintained a $60 price target on Solventum (NYSE:SOLV) stock. The analysts highlighted the company’s focus on transforming its corporate culture since the spin-off, noting stronger-than-expected employee engagement and leadership buy-in.
The primary goal for Solventum is to become more agile, improve R&D productivity, and increase its focus on healthcare. While there is ongoing debate about the balance between reinvesting for growth and maintaining margins, the analysts emphasized that repositioning the company towards faster-growing markets and boosting top-line volumes is the top priority.
There may be uncertainty about 2025 EPS projections due to this strategic shift, but the analysts expressed a preference for robust investment to drive long-term growth rather than pursuing more conservative measures.

Subscribe to get Latest News Updates

Latest News

You may like more
more

Affirm Upgraded by Wells Fargo to Overweight, Shares Jump 12 percent

Wells Fargo analysts upgraded Affirm Holdings (NASDAQ:AFRM) to Overweight,...

JPMorgan’s Net Interest Income Beats Forecasts, Shares Gain 4 percent

JPMorgan Chase & Co. (NYSE:JPM) reported robust third-quarter net...

Uber Shares Jump 10 percent as Tesla Robotaxi Event Fails to Impress

Uber Technologies (NYSE:UBER) saw its shares rise by 10%...

BlackRock Exceeds Q3 EPS and AUM Expectations, Stock Rise 3 percent

BlackRock (NYSE:BLK) shares rose more than 3% on Friday...